ATE380191T1 - Gemischtes olanzapinsolvat, verfahren zu dessen herstellung und verfahren zur herstellung von olanzapin-form i daraus - Google Patents

Gemischtes olanzapinsolvat, verfahren zu dessen herstellung und verfahren zur herstellung von olanzapin-form i daraus

Info

Publication number
ATE380191T1
ATE380191T1 AT05759149T AT05759149T ATE380191T1 AT E380191 T1 ATE380191 T1 AT E380191T1 AT 05759149 T AT05759149 T AT 05759149T AT 05759149 T AT05759149 T AT 05759149T AT E380191 T1 ATE380191 T1 AT E380191T1
Authority
AT
Austria
Prior art keywords
olnzapine
solvate
therefrom
mixed
producing
Prior art date
Application number
AT05759149T
Other languages
English (en)
Inventor
Barjoan Pere Dalmases
Bellmunt Jordi Bessa
Original Assignee
Inke Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inke Sa filed Critical Inke Sa
Application granted granted Critical
Publication of ATE380191T1 publication Critical patent/ATE380191T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT05759149T 2004-07-27 2005-07-07 Gemischtes olanzapinsolvat, verfahren zu dessen herstellung und verfahren zur herstellung von olanzapin-form i daraus ATE380191T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200401850A ES2253091B1 (es) 2004-07-27 2004-07-27 Solvato mixto de olanzapina, procedimiento para su obtencion y procedimiento de obtencion de la forma i de olanzapina a partir del mismo.

Publications (1)

Publication Number Publication Date
ATE380191T1 true ATE380191T1 (de) 2007-12-15

Family

ID=35064845

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05759149T ATE380191T1 (de) 2004-07-27 2005-07-07 Gemischtes olanzapinsolvat, verfahren zu dessen herstellung und verfahren zur herstellung von olanzapin-form i daraus

Country Status (13)

Country Link
US (1) US7759484B2 (de)
EP (1) EP1773841B1 (de)
JP (1) JP2008508254A (de)
KR (1) KR20070063496A (de)
AR (1) AR050359A1 (de)
AT (1) ATE380191T1 (de)
DE (1) DE602005003678T2 (de)
ES (2) ES2253091B1 (de)
PL (1) PL1773841T3 (de)
PT (1) PT1773841E (de)
TW (1) TWI295993B (de)
WO (1) WO2006013435A1 (de)
ZA (1) ZA200700670B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004058773A1 (en) 2002-12-24 2004-07-15 Teva Pharmaceutical Industries Ltd. Novel crystal forms of olanzapine, methods for their preparation and method for the preparation of known olanzapine crystal forms
CA2576862C (en) * 2004-07-14 2012-09-11 Jubilant Organosys Limited A process for producing pure form of 2-methyl-4-(4-methyl-1-piperazinyl)-10h-thieno[2,3-b][1,5]benzodiazepine
ES2292333B1 (es) * 2004-07-27 2008-12-16 Inke, S.A. Mejoras en el objeto de la patente principal n. 200401850, por "solvato mixto de olanzapina, procedimiento para su obtencion y procedimiento de obtencion de la forma i de olanzapina a partir del mismo".
ES2279715B1 (es) 2005-12-26 2008-06-01 Laboratorios Lesvi, S.L. Formulacion oral de olanzapina.
PL1968983T3 (pl) 2006-01-05 2011-05-31 Inke Sa Sposób wytwarzania mieszanego solwatu olanzapiny
CN102532158A (zh) * 2010-12-17 2012-07-04 北大方正集团有限公司 一种合成奥氮平的方法
JP6042153B2 (ja) * 2012-09-26 2016-12-14 株式会社トクヤマ オランザピンの製造方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9009229D0 (en) * 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
US5631250A (en) * 1995-03-24 1997-05-20 Eli Lilly And Company Process and solvate of 2-methyl-thieno-benzodiazepine
EG24221A (en) * 1995-03-24 2008-11-10 Lilly Co Eli Process for preparing olanzapine
US5637584A (en) * 1995-03-24 1997-06-10 Eli Lilly And Company Solvate of olanzapine
EG23659A (en) 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
CR5278A (es) * 1995-03-24 1996-07-04 Lilly Co Eli Formulacion oral de 2-metil-tieno-benzodiacepina
ZA978515B (en) 1996-09-23 1999-03-23 Lilly Co Eli Intermediates and process for preparing olanzapine
ID25533A (id) * 1997-09-30 2000-10-12 Lilly Co Eli Formulasi 2-metil-tieno-benzodiazepin
EP1119359B1 (de) * 1998-09-30 2004-05-26 Eli Lilly & Company 2-methyl-thieno-benzodiazepin-formulierung
IL154688A0 (en) 2000-08-31 2003-09-17 Reddys Lab Ltd Dr Hydrates of olanzapine and processes for the preparation thereof
WO2003055438A2 (en) 2001-12-24 2003-07-10 Sun Pharmaceutical Industries Limited Crystalline form i of 2-methyl-4-(4-methyl-1-piperazinyl) 10h thieno [2,3-b][1,5]benzodiazepine
PL196814B1 (pl) * 2002-05-17 2008-02-29 Inst Farmaceutyczny Sposób wytwarzania odmiany polimorficznej I olanzapiny i jej solwaty
DE60336226D1 (de) 2002-05-31 2011-04-14 Sandoz Ag Verfahren zur herstellung von olanzapin form i
SI21270A (sl) * 2002-07-15 2004-02-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Kristalne oblike olanzapina in postopki za njihovo pripravo
WO2004058773A1 (en) * 2002-12-24 2004-07-15 Teva Pharmaceutical Industries Ltd. Novel crystal forms of olanzapine, methods for their preparation and method for the preparation of known olanzapine crystal forms

Also Published As

Publication number Publication date
EP1773841A1 (de) 2007-04-18
PT1773841E (pt) 2008-02-20
AR050359A1 (es) 2006-10-18
ES2299049T3 (es) 2008-05-16
PL1773841T3 (pl) 2008-04-30
US7759484B2 (en) 2010-07-20
US20080280884A1 (en) 2008-11-13
KR20070063496A (ko) 2007-06-19
ZA200700670B (en) 2008-08-27
JP2008508254A (ja) 2008-03-21
DE602005003678T2 (de) 2008-11-20
WO2006013435A1 (en) 2006-02-09
ES2253091A1 (es) 2006-05-16
TWI295993B (en) 2008-04-21
ES2253091B1 (es) 2007-02-01
TW200613284A (en) 2006-05-01
DE602005003678D1 (de) 2008-01-17
EP1773841B1 (de) 2007-12-05

Similar Documents

Publication Publication Date Title
DE602005020467D1 (de) Dielektrische luneberglinse und verfahren zu ihrer herstellung
ATE408609T1 (de) Verfahren zur herstellung von n-phenylpyrazol-1- carboxamiden
ATE452883T1 (de) KRISTALLINE FORM VON 1-CHLOR-4-(ß-D-GLUCOPYRANOS- 1-YL)-2-Ä4-((S)-TETRAHYDROFURAN-3-YLOXY)- BENZYLÜBENZOL, VERFAHREN ZU DESSEN HERSTELLUNG UND DESSEN VERWENDUNG ZUR HERSTELLUNG VON MEDIKAMENTEN
EP1800317A4 (de) Isolatorbeschichtung und verfahren zu ihrer herstellung
DE602005019848D1 (de) Verfahren zur herstellung von tad- getrocknetem ti
DE602005026987D1 (de) Verfahren zur herstellung von 1,2-dichlorethan
DE50310782D1 (de) Piezoaktor und verfahren zu dessen herstellung
ATE482966T1 (de) Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide
DE602004008991D1 (de) Umlenkbeschlag und verfahren zu dessen herstellung
EP1906468A4 (de) Batteriedose und verfahren zu ihrer herstellung
DE602006013001D1 (de) Zusammensetzung mit verbesserter stabilität und verfahren zu ihrer herstellung
DE502005007762D1 (de) Verfahren zur herstellung von zahnrädern
ATE429820T1 (de) Durchlüftetes nahrungsmittel und verfahren zu seiner herstellung
ATE376997T1 (de) Verfahren zur herstellung von 1,4- diphenylazetidinon-derivaten
DE112005003550A5 (de) Flüssige Bio-Brennstoffmischung sowie Verfahren und Vorrichtung zur Herstellung derselben
DE602004028584D1 (de) Emulsionsförmiger haftklebstoff und verfahren zu seiner herstellung
ATE430140T1 (de) Verfahren zur herstellung von ä1,4,5ü- oxadiazepinderivaten
DE602004031350D1 (de) Penamkristall und verfahren zu dessen herstellung
DE502006009351D1 (de) Feinteiliges azopigment und verfahren zu seiner herstellung
ATA3752003A (de) Verbundwerkstoff und verfahren zu dessen herstellung
ATE488508T1 (de) Verfahren zur herstellung von irbesartan und zwischenprodukte davon
DE502004004318D1 (de) Verfahren zur herstellung von metall-matrix-verbundwerkstoffen
ATE406372T1 (de) Verfahren zur herstellung von 3-o-geschützten morphinonen und 3-o-geschützten morphinondienolcarboxylaten
ATE466843T1 (de) Verfahren zur herstellung von n-piperidino-1,5- diphenylpyrazol-3-carboxamid-derivaten
ATE380191T1 (de) Gemischtes olanzapinsolvat, verfahren zu dessen herstellung und verfahren zur herstellung von olanzapin-form i daraus

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties